Skip to main content
Advertisement
Advertisement

Europharma name consigned to history in group reshuffle

Jim-Roger Nordly during the Lofoten seminar. Photo: Ole Andreas Drønen.
Jim-Roger Nordly during the Lofoten seminar. Photo: Ole Andreas Drønen.

The name of fish vaccine and health products supplier Europharma is to disappear in a merger with its sister companies, Fishguard and ACD Pharma, to form a new company, STIM.

Advertisement

Europharma owner Jim-Roger Nordly revealed the news at the opening of the company’s annual fish health seminar in Lofoten, Norway yesterday.

“The time is right to join forces. Over the years we have amassed a broad range of competence and knowledge on just about every aspect relating to the biological production of fish. We want to utilise this competence more efficiently than we do as separate companies,” said Nordly.

Europharma is now part of STIM, which also includes Fishguard and ACD Pharma.
Europharma is now part of STIM, which also includes Fishguard and ACD Pharma.

‘Complete sense’

Europharma supplies its products to its home market of Norway, as well as to fish farmers in Scotland, Chile, Canada, Iceland and the Faroes.

Fishguard offers fish health services and environmental services for aquaculture, and the R&D company ACD Pharma has carried out research on the use of bacteriophages in aquaculture.

“No questions have easy answers when it comes to the biological production of fish. Everything relates to everything. That’s why joining forces makes complete sense. Our success depends on our ability to see the whole picture. We are now better equipped than ever to do just that,” said Nordly.

“I have to admit that getting rid of the Europharma name felt like going a bit far, but it is nothing but nostalgia. I am absolutely sure this is the right move for us.”

The Lofoten seminar concludes today. The seminar has 20 speakers, from Morway and abroad, including Norwegian Fisheries Minister Harald Tom Nesvik.

Advertisement